SCHEMBL7963322

SCHEMBL7963322

N#CC(=Cc1ccc(O)c(O)c1)S(=O)(=O)c1ccsc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.68
KDM4E B2RXH2 6/20 0.68
MEN1 O00255 6/20 0.68
ALDH1A1 P00352 6/20 0.68
KMT2A Q03164 6/20 0.68
HSD17B10 Q99714 5/20 0.68
TDP1 Q9NUW8 5/20 0.68
L3MBTL1 Q9Y468 4/20 0.68
ALOX15 P16050 4/20 0.68
ALOX12 P18054 4/20 0.68
PKM P14618 4/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
POLB P06746 3/20 0.68
ALPG P10696 2/20 0.68
GAA P10253 2/20 0.68
EGFR P00533 13/20 0.62
MAPT P10636 5/20 0.47
TP53 P04637 4/20 0.47
CYP1A2 P05177 4/20 0.47
BLM P54132 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963320 1.00 HPGD (0.68) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7963316 1.00 HPGD (0.68) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7952615 0.86 ALDH1A1 (0.51) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7952612 0.86 ALDH1A1 (0.51) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7952619 0.86 ALDH1A1 (0.51) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7964238 0.84 EGFR (0.64) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7964242 0.84 EGFR (0.64) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7964240 0.84 EGFR (0.64) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7962231 0.83 MEN1 (0.49) HPGDKDM4EMEN1ALDH1A1KMT2A
SCHEMBL7962230 0.83 MEN1 (0.49) HPGDKDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed